{
  "trial_id": "NCT01500720",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, disease stage, prior chemotherapy regimen, presence of CNS metastases, hemoglobin levels, absolute neutrophil count, platelet count, AST/SGOT levels, ALT/SGPT levels, alkaline phosphatase levels, total bilirubin levels, serum creatinine levels, creatinine clearance, history of myocardial infarction, history of angina pectoris, history of coronary/peripheral artery bypass graft, history of congestive heart failure, history of stroke or transient ischemic attack, HIV status, hepatitis B or C status, pregnancy status, reproductive potential and contraception use, hypersensitivity to polysorbate 80.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status",
          "ECOG performance status"
        ],
        [
          "Stage at Diagnosis",
          "disease stage"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Primary Tumor Site",
        "Number of Organs Involved"
      ],
      "remaining_candidate_features": [
        "prior chemotherapy regimen",
        "presence of CNS metastases",
        "hemoglobin levels",
        "absolute neutrophil count",
        "platelet count",
        "AST/SGOT levels",
        "ALT/SGPT levels",
        "alkaline phosphatase levels",
        "total bilirubin levels",
        "serum creatinine levels",
        "creatinine clearance",
        "history of myocardial infarction",
        "history of angina pectoris",
        "history of coronary/peripheral artery bypass graft",
        "history of congestive heart failure",
        "history of stroke or transient ischemic attack",
        "HIV status",
        "hepatitis B or C status",
        "pregnancy status",
        "reproductive potential and contraception use",
        "hypersensitivity to polysorbate 80"
      ]
    },
    "processed-gen-response": "Age, gender, ECOG performance status, disease stage, prior chemotherapy regimen, presence of CNS metastases, hemoglobin levels, absolute neutrophil count, platelet count, AST/SGOT levels, ALT/SGPT levels, alkaline phosphatase levels, total bilirubin levels, serum creatinine levels, creatinine clearance, history of myocardial infarction, history of angina pectoris, history of coronary/peripheral artery bypass graft, history of congestive heart failure, history of stroke or transient ischemic attack, HIV status, hepatitis B or C status, pregnancy status, reproductive potential and contraception use, hypersensitivity to polysorbate 80."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, ECOG Performance Status, Disease Stage, Prior Chemotherapy Regimen, Hemoglobin, Absolute Neutrophil Count, Platelet Count, AST/SGOT, ALT/SGPT, Alkaline Phosphatase, Total Bilirubin, Serum Creatinine, Creatinine Clearance,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Primary Tumor Site",
        "Stage at Diagnosis",
        "Number of Organs Involved"
      ],
      "remaining_candidate_features": [
        "Disease Stage",
        "Prior Chemotherapy Regimen",
        "Hemoglobin",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "AST/SGOT",
        "ALT/SGPT",
        "Alkaline Phosphatase",
        "Total Bilirubin",
        "Serum Creatinine",
        "Creatinine Clearance"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, ECOG Performance Status, Disease Stage, Prior Chemotherapy Regimen, Hemoglobin, Absolute Neutrophil Count, Platelet Count, AST/SGOT, ALT/SGPT, Alkaline Phosphatase, Total Bilirubin, Serum Creatinine, Creatinine Clearance"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological/Cytological Proven Small Cell Lung Cancer, Number of Prior Chemotherapy Regimens, Prior Treatment with Topotecan or Taxanes, Presence of CNS Metastases, History of Other Invasive Neoplasm, Presence of Leptomeningeal Metastases, Hemoglobin, Absolute Neutrophil Count, Platelet Count, AST/SGOT, ALT/SGPT, Alkaline Phosphatase, Total Bilirubin, Serum Creatinine.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Primary Tumor Site",
        "Stage at Diagnosis",
        "Number of Organs Involved"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Histological/Cytological Proven Small Cell Lung Cancer",
        "Number of Prior Chemotherapy Regimens",
        "Prior Treatment with Topotecan or Taxanes",
        "Presence of CNS Metastases",
        "History of Other Invasive Neoplasm",
        "Presence of Leptomeningeal Metastases",
        "Hemoglobin",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "AST/SGOT",
        "ALT/SGPT",
        "Alkaline Phosphatase",
        "Total Bilirubin",
        "Serum Creatinine"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Histological/Cytological Proven Small Cell Lung Cancer, Number of Prior Chemotherapy Regimens, Prior Treatment with Topotecan or Taxanes, Presence of CNS Metastases, History of Other Invasive Neoplasm, Presence of Leptomeningeal Metastases, Hemoglobin, Absolute Neutrophil Count, Platelet Count, AST/SGOT, ALT/SGPT, Alkaline Phosphatase, Total Bilirubin, Serum Creatinine."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, ECOG performance status, histological/cytological type of small cell lung cancer, measurable disease status, prior chemotherapy regimens, prior radiotherapy, prior surgery, time from prior treatment to randomization, presence of CNS metastases, presence of leptomeningeal metastases, history of other invasive neoplasms, cardiovascular risk factors, liver function tests, renal function tests, hemoglobin, absolute neutrophil count, platelet count.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Primary Tumor Site",
        "Stage at Diagnosis",
        "Number of Organs Involved"
      ],
      "remaining_candidate_features": [
        "histological/cytological type of small cell lung cancer",
        "measurable disease status",
        "prior chemotherapy regimens",
        "prior radiotherapy",
        "prior surgery",
        "time from prior treatment to randomization",
        "presence of CNS metastases",
        "presence of leptomeningeal metastases",
        "history of other invasive neoplasms",
        "cardiovascular risk factors",
        "liver function tests",
        "renal function tests",
        "hemoglobin",
        "absolute neutrophil count",
        "platelet count"
      ]
    },
    "processed-gen-response": "Age, sex, ECOG performance status, histological/cytological type of small cell lung cancer, measurable disease status, prior chemotherapy regimens, prior radiotherapy, prior surgery, time from prior treatment to randomization, presence of CNS metastases, presence of leptomeningeal metastases, history of other invasive neoplasms, cardiovascular risk factors, liver function tests, renal function tests, hemoglobin, absolute neutrophil count, platelet count."
  }
}